WINT

Windtree Therapeutics Stock Price

2.37
-0.09 (-3.66%)
Upgrade to Real-Time
Afterhours (Closed)
2.37
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Windtree Therapeutics Inc WINT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.09 -3.66% 2.37 20:00:01
Open Price Low Price High Price Close Price Prev Close
2.46 2.32 2.49 2.39 2.46
Bid Price Ask Price Spread News
2.34 2.42 0.08 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,542 362,246 $ 2.42 $ 875,587 17,217 2.06 - 10.06
Last Trade Time Type Quantity Stock Price Currency
19:58:34 59 $ 2.37 USD

Windtree Therapeutics Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 40.10M 16.92M 8.17M $ 198.00k $ - -2.52 -2.40
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Windtree Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical WINT Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week2.552.652.322.53610,131-0.18-7.06%
1 Month4.074.362.062.47867,436-1.70-41.77%
3 Months6.206.32992.062.80336,954-3.83-61.77%
6 Months5.757.5252.062.96167,022-3.38-58.78%
1 Year6.9510.062.063.85115,961-4.58-65.9%
3 Years6.9510.062.063.85115,961-4.58-65.9%
5 Years3.5310.060.752.72115,015-1.16-32.86%

Windtree Therapeutics Description

Windtree Therapeutics Inc is a development-stage biotechnology company focused on developing KL4 surfactant therapies for respiratory diseases. Its technology platform includes a synthetic, peptide-containing surfactant and novel drug delivery technologies that deliver aerosolized KL4 surfactant without invasive procedures. Its development program utilizing its proprietary technology platform is AEROSURF that is being developed for the treatment of respiratory distress syndrome in premature infants. It operates in the business segment of research and development of products focused on surfactant therapies for respiratory disorders and diseases, and the manufacture and commercial sales of approved products.


Your Recent History
NASDAQ
WINT
Windtree T..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.